83 Public Health Experts Urge European Commission: Excessive E-Cigarette Taxes Could Undermine Health Policy

Sep.02.2025
83 Public Health Experts Urge European Commission: Excessive E-Cigarette Taxes Could Undermine Health Policy
Eighty-three international experts in public health and tobacco control have co-signed a letter to the European Commission warning that the forthcoming revision of the Tobacco Excise Directive could seriously harm public health if it imposes high taxes on lower-risk alternatives such as e-cigarettes, heated tobacco, and nicotine pouches. The experts argue that the EU’s stance that “non-combustible nicotine products carry risks comparable to cigarettes” contradicts scientific evidence.

Key Points

 

  • Signatories: 83 international experts in public health and tobacco control jointly sent the letter.
  • Main request: Oppose taxing e-cigarettes, heated tobacco, and nicotine pouches at levels comparable to conventional cigarettes.
  • Evidence base: Experiences in countries such as Sweden, the UK, and New Zealand show that lower-risk products can significantly reduce smoking rates and disease burden.
  • Policy risk: High excise taxes would hinder smoking cessation and switching, effectively protecting the cigarette trade and straying from evidence-based policymaking.
  • Public-health outlook: If the EU pursues a “high-tax strategy,” it may set a negative global example, especially for low- and middle-income countries.

 


 

2Firsts, September 2, 2025 — According to EUreporter, 83 international experts in public health, nicotine dependence, and tobacco control have written to the President of the European Commission and the College of Commissioners to express concerns about the EU’s upcoming revision of the Tobacco Excise Directive. They warn that imposing high taxes on lower-risk nicotine alternatives—e-cigarettes, heated tobacco products, and nicotine pouches—would stall harm-reduction progress and directly damage public health.

 

In their letter, the experts note that recent public statements by EU officials suggesting that “non-combustible nicotine products pose risks comparable to cigarettes” are at odds with existing scientific evidence and run counter to the principles of evidence-based public health policy.

 

They emphasize that smoking remains the leading cause of preventable death in the EU, causing nearly 700,000 premature deaths annually. Currently, 26% of EU adults (29% among those aged 15–24) smoke. A large body of research shows that non-combustible products—e-cigarettes, heated tobacco, and nicotine pouches—are significantly less harmful than cigarettes and have helped millions of smokers quit.

 

The experts cite international experience to support their position:

 

  • Sweden: With widespread use of snus and nicotine pouches, daily tobacco use is the lowest in the EU (<5%), and cancer incidence is 41% lower than the EU average.

 

  • United Kingdom: The government encourages smokers to switch to vaping; smoking prevalence fell from 17% to 12% over five years.

 

  • New Zealand: Daily smoking declined from 16% in 2011/12 to 7% in 2023/24, while daily vaping rose to 11% over the same period.

 

 

The letter stresses that while protecting minors is essential, this can be achieved by strictly enforcing existing restrictions on advertising and sales rather than imposing high taxes that deter adult smokers from switching to lower-risk products.

 

The authors state bluntly: “If fiscal and regulatory measures prevent smokers from moving to lower-risk alternatives, that is not only unethical; it effectively protects the cigarette trade.”

 

They conclude that EU public health is at a critical crossroads. In the coming months, the EU plans to advance both the Tobacco Products Directive (TPD) and the Tobacco Excise Directive. A “tax raid” on lower-risk products, they warn, would keep more people smoking cigarettes, harm public health, and set a negative precedent worldwide—especially for low- and middle-income countries.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
During FDA’s Feb 10 PMTA roundtable (manufacturing controls panel), small ENDS manufacturers warned that uncertainty in manufacturing expectations creates existential financial risk. FDA officials reiterated review flexibility is constrained by statutory and scientific boundaries. The panel debated testing standards, documentation requirements, open-system responsibility, supply chain changes, and software updates—highlighting unresolved PMTA challenges for small manufacturers.
Feb.11
New York Says Seized Illegal Vape Shipment Had Retail Value of USD 2.2 Million to USD 3.5 Million
New York Says Seized Illegal Vape Shipment Had Retail Value of USD 2.2 Million to USD 3.5 Million
New York state health officials said a joint operation last week involving the State Department of Health, Nassau County police and local health officials intercepted about 14 tons of illegal vape products that were intended for local distributors and smoke shops.
Mar.20 by 2FIRSTS.ai
TPB Q4 FY2025 Revenue Rises 29% to $121 Million; Modern Oral Business Up 266% Year Over Year
TPB Q4 FY2025 Revenue Rises 29% to $121 Million; Modern Oral Business Up 266% Year Over Year
Turning Point Brands, a U.S. nicotine and tobacco-related consumer products company, reported its fiscal 2025 fourth-quarter results: quarterly revenue was $121 million, up 29% year over year; adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) was $30 million, up 14%. Net revenue from modern oral nicotine products was $41.3 million, up 266% year over year.
Mar.03 by 2FIRSTS.ai
USITC Launches Section 337 Probe Into Disposable and Closed-System ENDS, Involving 16 Companies
USITC Launches Section 337 Probe Into Disposable and Closed-System ENDS, Involving 16 Companies
The U.S. International Trade Commission (USITC) voted to institute a Section 337 investigation into certain disposable and other closed-system electronic nicotine delivery systems (ENDS) devices and components thereof (Inv. No. 337-TA-1486). The investigation stems from a complaint filed on January 13, 2026 by R.J. Reynolds entities based in Winston-Salem, North Carolina, supplemented on February 3, 2026.
Mar.05 by 2FIRSTS.ai
Ireland’s Tobacco and Vape Retail Licensing Regime Takes Effect; BAT Says It Should Cover Nicotine Pouches
Ireland’s Tobacco and Vape Retail Licensing Regime Takes Effect; BAT Says It Should Cover Nicotine Pouches
Ireland’s retail licensing system took effect on Feb. 2, 2026, charging annual fees per point of sale and enforced by the Health Service Executive (HSE). British American Tobacco’s local unit, BAT Ireland, said excluding nicotine pouches could leave a regulatory gap.
Feb.04 by 2FIRSTS.ai
Product | VOZOL launches new GEAR-series device in the UK and UAE, featuring a 2.1-inch colour screen and sound interaction
Product | VOZOL launches new GEAR-series device in the UK and UAE, featuring a 2.1-inch colour screen and sound interaction
Vape brand VOZOL has recently listed a disposable shisha-style product, the GEAR HOOKAH 40000, on its official website. Public information shows the device comes with a 26ml e-liquid capacity, offers 3mg/ml and 5mg/ml nicotine strengths, and is marketed at 25,000–40,000 puffs. It is currently available via selected online retail channels in the UK and the UAE.
Feb.04 by 2FIRSTS.ai